Masimo Corp. Stock
Price
Target price
€156.00
€156.00
-
-
-
€171.48
10.08.26 / Tradegate
WKN: 578074 / Symbol: MASI / Name: Masimo / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Masimo Corp. Stock
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Masimo Corp..
With a target price of 171 € there is a slightly positive potential of 9.62% for Masimo Corp. compared to the current price of 156.0 €.
Pros and Cons of Masimo Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | - | 0.000% | 0.000% | 25.857% | 40.288% | 44.981% | -33.333% |
| Bio-Rad Labs Inc. A | -0.980% | 5.636% | 23.752% | 35.419% | 19.193% | -15.223% | -53.069% |
| Penumbra Inc | -0.350% | -0.285% | 0.576% | 35.794% | 4.955% | 24.821% | 23.717% |
| CONMED Corp. | -0.470% | -5.381% | 27.108% | -7.456% | 20.571% | -58.627% | -60.561% |
Comments
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
This $7 Million Masimo Exit Came Before a 34% Surge on $9.9 Billion Acquisition
On February 17, 2026, Bridger Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Masimo (NASDAQ:MASI).
According to a Securities and
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
On February 17, 2026, Parkman Healthcare Partners disclosed a new position in Masimo Corporation (NASDAQ:MASI), acquiring 200,000 shares in the fourth quarter worth an estimated $26.01 million at
Naya Capital Adds Masimo Shares
According to an SEC filing dated Feb. 18, Naya Capital Management UK Ltd disclosed a new position in Masimo (NASDAQ:MASI), acquiring nearly 1.6 million shares.
Masimo is a leading provider of